The efficiency of intraperitoneal high-dose immunoglobulin in experimental nephrotic syndrome

Pediatric Nephrology

Volumn 21, Issue 1, 2006, Pages 39-45

  Erisir, Seyhan ^a   Akbas, Halide ^a   Koyun, Mustafa ^a   Akman, Sema ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Adriamycin induced nephrotic syndrome; Immunoglobulin; Rat; Treatment

Indexed keywords

ALBUMIN; CREATININE; DOXORUBICIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PROTEIN; TRIACYLGLYCEROL;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLORIMETRY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; DRUG MEGADOSE; GLOMERULOSCLEROSIS; MALE; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RAT STRAIN; SCORING SYSTEM; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; TURBIDIMETRY;

ANIMALS; IMMUNOGLOBULINS, INTRAVENOUS; INJECTIONS, INTRAPERITONEAL; MALE; NEPHROTIC SYNDROME; RATS; RATS, WISTAR;

EID: 29944435688     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-2046-y     Document Type: Article

References (38)

1. Broyer M, Meyrier A, Niaudet P, Habib R (1998) Minimal changes and focal segmental glomerulosclerosis. In: Davison AM, Cameron JS, Grünfeld JP, Kerr DNS, Ritz E, Winearls CG (eds) Oxford textbook of Clinical Nephrology, 2nd edn, Oxford University Press, New York, pp 493-535
2. Grond J, Weening JJ, Elema JD (1984) Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside. Lab Invest 51(3):277-285 6471809
3. Sakemi T, Ohtsuka N, Tomiyoshi Y, Morito F (1996) Sex difference in progression of adriamycin-induced nephropathy in rats. Am J Nephrol 16:540-547 8955769
4. Okasora T, Takikawa T, Utsunomiya Y, Senoh I, Hayashibara H, Shiraki K, Kasagi T, Shimizu F (1992) Suppressive effect of superoxide dismutase on adriamycin nephropathy. Nephron 60:199-203 1553005
5. Van den Branden C, Ceyssens B, De Craemer D, Pauwels M, Vanden Houte K, De Bleser P, Hellemans K, Geerts A, Verbeelen D (2000) Renal antioxidant enzymes and fibrosis-related markers in the rat adriamycin model. Nephron 86:167-175 10.1159/000045736
6. Ozen S, Usta Y, Sahin-Erdemli I, Orhan D, Gumusel B, Yang B, Gursoy Y, Tulunay O, Dalkara T, Bakkaloglu A, El-Nahas M (2001) Association of nitric oxide production and apoptosis in a model of experimental nephropathy. Nephrol Dial Transplant 16:32-38 10.1093/ndt/16.1.32
7. Bricio T, Molina A, Mampaso F (1992) Effect of anti-interleukin-1 administration to rats with adriamycin-induced nephrosis. APMIS 100(5):401-407 1586478
8. Intravenous immunoglobulin: The National Institutes of Health Consensus Development Conference on Intravenous Immunoglobulin: Prevention and Treatment of Disease (1990). Consens Statement May 21-23 8(5):1-23
9. Boletis JN, Ioannidis JP, Boki KA, Moutsopoulos HM (1999) Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis. Lancet 354(9178):569-570 10.1016/S0140-6736(99)01575-5
10. Hundt M, Manger K, Dorner T, Grimbacher B, Kalden P, Rascu A, Weber D, Burmester GR, Peter HH, Kalden JR, Schmidt RE (2000) Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin. Rheumatology 39:1301-1302 10.1093/rheumatology/39.11.1301
11. Yokoyama H, Goshima S, Wada T, Takaeda M, Furuichi K, Kobayashi K, Kida H (1999) The short- and long-term outcomes of membranous nephropathy treated with intravenous immune globulin therapy. Kanazawa Study Group for Renal Diseases and Hypertension. Nephrol Dial Transplant 14(10):2379-2386 10.1093/ndt/14.10.2379
12. Welch TR, McAdams AJ, Beischel LS (1995) Glomerulonephritis associated with complete deficiency of the fourth component of complement. Response to intravenous immunoglobulin. Arthritis Rheum 38(9):1333-1337 7575730
13. Rostoker G, Desvaux-Belghiti D, Pilatte Y, Petit-Phar M, Philippon C, Deforges L, Terzidis H, Intrator L, André C, Adnot S, Bonin P, Bierling P, Rémy P, Lagrue G, Lang P, Weil B (1994) High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schonlein purpura. Ann Intern Med 120(6):476-484 8311370
14. Kusuda A, Migita K, Tsuboi M, Degawa M, Matsuoka N, Tominaga M, Kawakami A, Kawabe Y, Taguchi T, Eguchi K (1999) Successful treatment of adult-onset Henoch-Schonlein purpura nephritis with high-dose immunoglobulins. Intern Med 38(4):376-379 10361914
15. Blanchette VS, Kirby MA, Turner C (1992) Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Semin Hematol 29:72-82 1509297
16. Debre M, Bonnet MC, Fridman WH, Carosella E, Philippe N, Reinert P, Vilmer E, Kaplan C, Teillaud JL, Griscelli C (1993) Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 342:945-949 10.1016/0140-6736(93)92000-J
17. Jungi TW, Brcic M, Kuhnert P, Spycher MO, Li F, Nydegger UE (1990) Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by human monocytes. Clin Exp Immunol 82:163-169 2208790
18. Abe Y, Horiuchi A, Miyake M, Kimura S (1994) Anti-cytokine nature of natural human immunoglobulin: One possible mechanism of the clinical effect of intravenous immunoglobulin therapy. Immunol Rev 139:5-19 7927413
19. Andersson UG, Bjork L, Skansén-Saphir U, Andersson JP (1993) Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology 79:211-216 8344700
20. Bendtzen K, Hansen MB, Ross C, Poulsen LK, Svenson M (1995) Cytokines and autoantibodies to cytokines. Stem Cells 13:206-222 7613489
21. Basta M, Fries LF, Frank MM (1991) High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes. Blood 77:376-380 1985703
22. Dietrich G, Kaveri SV, Kazatchkine MD (1992) Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 62:S73-S81 10.1016/0090-1229(92)90044-O
23. Toungouz M, Denys CH, De Groote D, Dupont E (1995) In vitro inhibition of tumour necrosis factor-alpha and interleukin-6 production by intravenous immunoglobulins. Br J Haematol 89:698-703 7772505
24. Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2(7880):556-560 10.1016/S0140-6736(74)91880-7
25. Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: Evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10:529-537 10073603
26. Stefanovic V, Golubovic E, Mitic-Zlatkovic M, Vlahovic P, Jovanovic O, Bogdanovic R (1998) Interleukin-12 and interferon-gamma production in childhood idiopathic nephrotic syndrome. Pediatr Nephrol 12:463-466 10.1007/s004670050488
27. Sahali D, Pawlak A, Le Gouvello S, Lang P, Valanciute A, Remy P, Loirat C, Niaudet P, Bensman A, Guellaen G (2001) Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol 12:1648-1658 11461937
28. Cao C, Lu S, Dong C, Zhao R (2001) Abnormal DNA-binding of transcription factors in minimal-change nephrotic syndrome. Pediatr Nephrol 16:790-795 10.1007/s004670100632
29. Raij L, Azar S, Keane W (1984) Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26:137-143 6239058
30. Benchetrit S, Golan E, Podjarny E, Green J, Rashid G, Bernheim J, Hershkovitz R, Bernheim J (2001) Low molecular weight heparin reduces proteinuria and modulates glomerular TNF alpha production in the early phase of adriamycin nephropathy. Nephron 87:155-160 10.1159/000045905
31. Zima T, Tesar V, Stipek S, Crkovska J, Poledne R, Teminova J, Platenik J, Rychlik I, Merta M, Nemecek K (1997) The influence of cyclosporine on lipid peroxidation and superoxide dismutase in adriamycin nepropathy in rats. Nephron 75:464-468 9127335
32. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Fujishima M (1986) Adriamycin- induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29:502-510 3486312
33. Washio M, Nanishi F, Okuda S, Onoyama K, Fujishima M (1994) Alpha tocopherol improves focal glomerulosclerosis in rats with adriamycin-induced progressive renal failure. Nephron 68:347-352 7838258
34. Amore A, Mazzucco G, Cavallo F, Forni G, Gianoglio B, Motta M, Peruzzi L, Novelli F, Porcellini MG, Cesano G, Coppo R (1996) Adriamycin-induced proteinuria in nude mice: An immune-system-mediated toxic effect. Nephrol Dial Transplant 11:1012-1018 8671961
35. Rangan GK, Wang Y, Tay YC, Harris DC (2000) Cytokine gene expression in adriamycin nephropathy: Effects of antioxidant nuclear factor kappaB inhibitors in established disease Nephron 86:482-490
36. Nangaku M, Pippin J, Richardson CA, Schulze M, Young BA, Alpers CE, Gordon KL, Johnson RJ, Couser WG (1996) Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy. Kidney Int 50:2054-2062 8943490
37. Bhol KC, Desai A, Kumari S, Colon JE, Ahmed AR (2001) Pemphigus vulgaris: The role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production. Clin Immunol 100:172-180 10.1006/clim.2001.5061
38. Aukrust P, Muller F, Svenson M, Nordoy I, Bendtzen K, Froland SS (1999) Administration of intravenous immunoglobulin (IVIG) in vivo-down-regulatory effects on the IL-1 system. Clin Exp Immunol 115:136-143 10.1046/j.1365-2249.1999.00757.x